Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
15.01
+0.36 (2.46%)
At close: May 12, 2025, 4:00 PM
14.55
-0.46 (-3.06%)
After-hours: May 12, 2025, 6:16 PM EDT
Mineralys Therapeutics Employees
Mineralys Therapeutics had 51 employees as of December 31, 2024. The number of employees increased by 23 or 82.14% compared to the previous year.
Employees
51
Change (1Y)
23
Growth (1Y)
82.14%
Revenue / Employee
n/a
Profits / Employee
-$3,696,333
Market Cap
973.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51 | 23 | 82.14% |
| Dec 31, 2023 | 28 | 16 | 133.33% |
| Dec 31, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MLYS News
- 4 hours ago - Mineralys Therapeutics, Inc. (MLYS) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 8 hours ago - Mineralys Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 days ago - Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference - GlobeNewsWire
- 7 days ago - Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025 - GlobeNewsWire
- 19 days ago - Mineralys Therapeutics Announces Publication of Pivotal Phase 2 Advance-HTN Results in the New England Journal of Medicine (NEJM) - GlobeNewsWire
- 6 weeks ago - Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology's Annual Scientific Session & Expo (ACC.25) - GlobeNewsWire
- 6 weeks ago - Mineralys Therapeutics to Host KOL Call to Discuss Clinical Data from Launch-HTN and Advance-HTN Pivotal Trials Tuesday, April 1, 2025, at 8:00 AM ET - GlobeNewsWire
- 7 weeks ago - Mineralys Therapeutics Announces Closing of Underwriters' Option to Purchase Additional Shares in Connection with Public Offering of Common Stock - GlobeNewsWire